Graft Versus Host Disease Clinical Trial Pipeline Shows Promising Momentum as 45+ Pharma Companies Advance Research
The clinical trial pipeline for graft versus host disease (GVHD) demonstrates significant research activity as more than 45 pharmaceutical companies...
